CAS 1104630-93-4

3-Bromothieno[3,2-b]pyridine-2-carboxylic acid

Description:

3-Bromothieno[3,2-b]pyridine-2-carboxylic acid is a heterocyclic compound characterized by the presence of a bromine atom, a thieno ring, and a pyridine structure, along with a carboxylic acid functional group. This compound features a fused bicyclic system, which contributes to its unique chemical properties and potential reactivity. The bromine substituent can influence the compound's electronic properties, making it a candidate for various chemical reactions, including nucleophilic substitutions and cross-coupling reactions. The carboxylic acid group enhances its solubility in polar solvents and can participate in acid-base reactions. Additionally, the thieno and pyridine moieties may impart biological activity, making this compound of interest in medicinal chemistry and material science. Its specific applications can vary, but it may be explored for use in pharmaceuticals, agrochemicals, or as a building block in organic synthesis. As with many heterocycles, the compound's stability and reactivity can be influenced by the surrounding functional groups and the overall molecular environment.

Formula: C₈H₄BrNO₂S

InChI: InChI=1S/C8H4BrNO2S/c9-5-6-4(2-1-3-10-6)13-7(5)8(11)12/h1-3H,(H,11,12)

InChI key: InChIKey=AQXGWYFJQUCGCC-UHFFFAOYSA-N

SMILES: BrC=1C=2C(SC1C(O)=O)=CC=CN2

Synonyms:

• 3-Bromothieno[3,2-b]pyridine-2-carboxylic acid
• Thieno[3,2-b]pyridine-2-carboxylic acid, 3-bromo-

3-Bromothieno[3,2-B]Pyridine-2-Carboxylic Acid

CAS: 1104630-93-4

Formula: C₈H₄BrNO₂S

Purity: 97%

Color and Shape: Solid

Molecular weight: 258.0919

Ref: IN-DA0096XN

3-Bromothieno[3,2-b]pyridine-2-carboxylic acid

CAS: 1104630-93-4

Purity: 98%

Molecular weight: 258.0899963

Ref: 10-F624586

3-Bromothieno[3,2-b]pyridine-2-carboxylic acid

CAS: 1104630-93-4

3-Bromothieno[3,2-b]pyridine-2-carboxylic acid (BTPC) is a synthetic compound that has been found to have cytotoxic activity against cancer cells. It has also been shown to induce apoptosis in tumor cell lines and inhibit the growth of colorectal adenocarcinoma cells. BTPC was found to be more potent than the natural product halolactonization, which is a lactone with antitumor activity. The mechanism for BTPC's cytotoxicity involves its inhibition of the synthesis of RNA and DNA, which leads to cell death. This drug also inhibits angiogenesis and reduces blood supply to tumors.

Formula: C₈H₄BrNO₂S

Purity: Min. 95%

Molecular weight: 258.09 g/mol

Ref: 3D-EUB63093